Table 1.
ECHO (%) | RV (%) | Fibrosis (%) | |
---|---|---|---|
DXR (n=22) | 71.8 ± 10.1 | 60.6 ± 12.5 | 8.7 ± 3.2 |
Control (n=7) | 83.5 ± 5 | 82.8 ± 2.8 | 2.3 ± 1 |
p | 0.002 | <0.0001 | <0.0001 |
ECHO: echocardiography; RV: radionuclide ventriculography, DXR: doxorubicin.
ECHO (%) | RV (%) | Fibrosis (%) | |
---|---|---|---|
DXR (n=22) | 71.8 ± 10.1 | 60.6 ± 12.5 | 8.7 ± 3.2 |
Control (n=7) | 83.5 ± 5 | 82.8 ± 2.8 | 2.3 ± 1 |
p | 0.002 | <0.0001 | <0.0001 |
ECHO: echocardiography; RV: radionuclide ventriculography, DXR: doxorubicin.